scholarly journals A Biopsy-Negative Esophageal Cancer: Diagnosis by Combination of Bite Biopsy and Endoscopic Mucosal Resection Using a Cap-Fitted Panendoscope (EMRC)

Endoscopy ◽  
2001 ◽  
Vol 33 (04) ◽  
pp. 386-386 ◽  
Author(s):  
T. Yokoyama ◽  
N. Nakamura ◽  
K. Kiyosawa ◽  
T. Akamatsu
Keyword(s):  
Esophageal Cancer ◽  
Endoscopic Mucosal Resection ◽  
Cancer Diagnosis ◽  
Mucosal Resection

Endoscopic Surgery of the Broncho-esophageal Diseases. Endoscopic Mucosal Resection in Early Esophageal Cancer.

1996 ◽  
Vol 47 (2) ◽  
pp. 150-154 ◽  
Author(s):  
Hiroyasu Makuuchi ◽  
Hideo Shimada ◽  
Kyoichi Mizutani ◽  
Osamu Chino ◽  
Takao Machimura ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Endoscopic Mucosal Resection ◽  
Endoscopic Surgery ◽  
Early Esophageal Cancer ◽  
Esophageal Diseases ◽  
Mucosal Resection

7046 Endoscopic mucosal resection using a cap method (emr-c) provides safe and effective treatment for early esophageal cancer.

2000 ◽  
Vol 51 (4) ◽  
pp. AB253 ◽  
Author(s):  
David E. Fleischer ◽  
Guo Qing Wang ◽  
Gui Qi Wang ◽  
Norman S. Nishioka ◽  
Brett Bouma ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Effective Treatment ◽  
Endoscopic Mucosal Resection ◽  
Early Esophageal Cancer ◽  
Mucosal Resection ◽  
Cap Method

Clinical outcome of endoscopic mucosal resection (EMR) in clinical stage I (cSt I ) esophageal cancer

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e15569-e15569
Author(s):  
T. Yoshii ◽  
S. Tamai ◽  
N. Aoyama ◽  
J. Minamide ◽  
S. Takagi ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Endoscopic Mucosal Resection ◽  
Clinical Stage ◽  
Therapeutic Modality ◽  
Multiple Primary Cancers ◽  
Poor Performance Status ◽  
Muscularis Mucosa ◽  
Mucosal Resection ◽  
Concurrent Disease

e15569 Background: When a tumor invades to the muscularis mucosa or submucosal layer (T1a-MM or T1b, in Japan), cSt I esophageal cancer(EC) has 10–50%. risk of lymph node metastasis (LNM). Surgery, though very invasive, is the standard radical therapy for the patients(pts.) with such stage EC. Endoscopic mucosal resection (EMR), which conserves the esophagus, is a minimally invasive and attractive therapeutic modality for such pts. However, the clinical outcomes of EMR for these pts. have been not fully elucidated. Methods: We conducted retrospective analysis of the clinical courses of 44 pts. who underwent EMR for newly diagnosed T1a-MM or T1bcN0M0 EC between 1994 and 2007at our hospital, and who could be followed up for at least 1 year. Statistical analysis was performed by the Kaplan-Meier methods and the Cox proportional hazard model. Results: Patients decided on the following treatments immediately after EMR based on informed consent and their general condition; 2 underwent surgery, one underwent prophylactic chemotherapy(CHT) and 41 selected follow-up without any additional therapy. Of the 41, 20 selected this course by choice, 12 because of severe concurrent disease; 2 because of poor performance status and 7 because of other multiple primary cancers (MPCs). Twelve pts. died; 2 were cause specific; (4.5%), 8 from MPCs and, 2 from unknown causes. Median age was 67 years old (range 53–80), and 5 were female. No critical comlications were noted. Median follow-up time was 1542days (375–3786). 5 developed LNM. One with prophylactic CHT, was followed by surgery, and another was followed by CHT, who showed cause specific deaths later. Other 3 pts. followed by chemoradiotherapy, did not show cause specific death. Overall and cause specific survival rates at 5 years were 67.3% and 91.8%, respectively. Multivariate analysis revealed that either severe concurrent disease or MPCs significanctly influenced survival (p=0.041, HR 5.437(95%CI 1.073–25.542)). 8 and 6 pts. developed metachronous EC and local recurrence, respectively. Apart from one, they could be retreated endoscopicaly. Conclusions: EMR is a very useful therapeutic modality for cSt I EC, not only for local control but also as a clinically sufficient treatment; especially in pts. with severe concurrent disease. No significant financial relationships to disclose.

Extensive (8 to 12 cm2) Noncircumferential Endoscopic Mucosal Resection for Early Esophageal Cancer

2010 ◽  
Vol 89 (6) ◽  
pp. S2151-S2155 ◽  
Author(s):  
Philippe Monnier ◽  
Yves Jaquet ◽  
Alexandre Radu ◽  
Raphaelle Pilloud ◽  
Pierre Grosjean ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Endoscopic Mucosal Resection ◽  
Early Esophageal Cancer ◽  
Mucosal Resection
Sign in / Sign up

Export Citation Format

Share Document